These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8532107)

  • 21. Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?
    Licastro F; Pedrini S; Caputo L; Annoni G; Davis LJ; Ferri C; Casadei V; Grimaldi LM
    J Neuroimmunol; 2000 Feb; 103(1):97-102. PubMed ID: 10674995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination of serum markers related to several mechanisms in Alzheimer's disease.
    Teunissen CE; Lütjohann D; von Bergmann K; Verhey F; Vreeling F; Wauters A; Bosmans E; Bosma H; van Boxtel MP; Maes M; Delanghe J; Blom HJ; Verbeek MM; Rieckmann P; De Bruijn C; Steinbusch HW; de Vente J
    Neurobiol Aging; 2003 Nov; 24(7):893-902. PubMed ID: 12928047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The significance of measurement of contents of serum serine protease inhibitors in senile dementia of the Alzheimer type].
    Amari M; Matsubara E; Ishiguro K; Shoji M; Hirai S
    Rinsho Shinkeigaku; 1989 Oct; 29(10):1256-60. PubMed ID: 2605832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammatory markers in matched plasma and cerebrospinal fluid from patients with Alzheimer's disease.
    Sun YX; Minthon L; Wallmark A; Warkentin S; Blennow K; Janciauskiene S
    Dement Geriatr Cogn Disord; 2003; 16(3):136-44. PubMed ID: 12826739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostaglandin E2 induced polymerization of human alpha-1-antichymotrypsin and suppressed its protease inhibitory activity: implications for Alzheimer's disease.
    Licastro F; Davis LJ; Pedrini S; Galasko D; Masliah E
    Biochem Biophys Res Commun; 1998 Aug; 249(1):182-6. PubMed ID: 9705853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism.
    Kamboh MI; Sanghera DK; Ferrell RE; DeKosky ST
    Nat Genet; 1995 Aug; 10(4):486-8. PubMed ID: 7670501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of genetic associations of alpha-1-antichymotrypsin polymorphism with alzheimer-type neuropathological changes or sporadic Alzheimer's disease.
    Sodeyama N; Yamada M; Itoh Y; Suematsu N; Matsushita M; Otomo E; Mizusawa H
    Dement Geriatr Cogn Disord; 1999; 10(3):221-5. PubMed ID: 10325450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood-brain barrier permeability of the demented elderly as studied by cerebrospinal fluid-serum albumin ratio.
    Wada H
    Intern Med; 1998 Jun; 37(6):509-13. PubMed ID: 9678683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of elevated alpha 1-antichymotrypsin with cognitive impairment in a prospective study of the very old.
    Gabriel SM; Marin DB; Aisen PS; Lantz M; Altstiel LD; Davis KL; Mohs RC
    Am J Psychiatry; 1998 May; 155(5):698-700. PubMed ID: 9585727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. alpha 1-Antichymotrypsin as a risk modifier for late-onset Alzheimer's disease in Japanese apolipoprotein E epsilon 4 allele carriers.
    Yoshiiwa A; Kamino K; Yamamoto H; Kobayashi T; Imagawa M; Nonomura Y; Yoneda H; Sakai T; Nishiwaki Y; Sato N; Rakugi H; Miki T; Ogihara T
    Ann Neurol; 1997 Jul; 42(1):115-7. PubMed ID: 9225693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No association between the alpha 1-antichymotrypsin A allele and Alzheimer's disease.
    Murphy GM; Sullivan EV; Gallagher-Thompson D; Thompson LW; van Duijn CM; Forno LS; Ellis WG; Jagust WJ; Yesavage J; Tinklenberg JR
    Neurology; 1997 May; 48(5):1313-6. PubMed ID: 9153464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of plasma biomarkers and clinical data for the detection of sporadic Alzheimer's disease.
    Han Y; Jia J; Jia XF; Qin W; Wang S
    Neurosci Lett; 2012 May; 516(2):232-6. PubMed ID: 22503901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No association between alpha1-antichymotrypsin polymorphism, apolipoprotein E and patients with late-onset Alzheimer's disease.
    Helisalmi S; Mannermaa A; Lehtovirta M; Ryynänen M; Riekkinen P; Soininen H
    Neurosci Lett; 1997 Aug; 231(1):56-8. PubMed ID: 9280167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased levels of alpha-1-antichymotrypsin in brains of patients with Alzheimer's disease correlate with activated astrocytes and are affected by APOE 4 genotype.
    Licastro F; Mallory M; Hansen LA; Masliah E
    J Neuroimmunol; 1998 Aug; 88(1-2):105-10. PubMed ID: 9688331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absence of association of alpha1-antichymotrypsin polymorphisms with Alzheimer's disease: a report on autopsy-confirmed cases.
    Itabashi S; Arai H; Matsui T; Matsushita S; Muramatsu T; Higuchi S; Trojanowski JQ; Sasaki H
    Exp Neurol; 1998 Jun; 151(2):237-40. PubMed ID: 9628759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alpha-antichymotrypsin gene polymorphism and risk for Alzheimer's disease in the Spanish population.
    Ezquerra M; Blesa R; Tolosa E; Ballesta F; Oliva R
    Neurosci Lett; 1998 Jan; 240(2):107-9. PubMed ID: 9486483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased chemiluminescence response of neutrophils from the peripheral blood of patients with senile dementia of the Alzheimer's type.
    Licastro F; Morini MC; Davis LJ; Malpassi P; Cucinotta D; Parente R; Melotti C; Savorani G
    J Neuroimmunol; 1994 Apr; 51(1):21-6. PubMed ID: 8157733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No association between alpha 1-antichymotrypsin and familial Alzheimer's disease.
    Haines JL; Pritchard ML; Saunders AM; Schildkraut JM; Growdon JH; Gaskell PC; Farrer LA; Auerbach SA; Gusella JF; Locke PA; Rosi BL; Yamaoka L; Small GW; Conneally PM; Roses AD; Pericak-Vance M
    Ann N Y Acad Sci; 1996 Dec; 802():35-41. PubMed ID: 8993482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alpha 1-antitrypsin and alpha 1-antichymotrypsin are in the lesions of Alzheimer's disease.
    Gollin PA; Kalaria RN; Eikelenboom P; Rozemuller A; Perry G
    Neuroreport; 1992 Feb; 3(2):201-3. PubMed ID: 1623174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No interaction between the APOE and the alpha-1-antichymotrypsin genes on risk for Alzheimer's disease.
    Fallin D; Reading S; Schinka J; Hoyne J; Scibelli P; Gold M; Crawford F; Mullan M
    Am J Med Genet; 1997 Apr; 74(2):192-4. PubMed ID: 9129722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.